FDA Approves Nasal Spray Flu Vaccine for At-Home Use

The first-ever needleless flu vaccine that can be given at home was just approved by the U.S. Food and Drug Administration. FluMist is a nasal spray that provides protection against influenza A and B, and it’s now approved for self-administration in adults up to age 49 and caregiver-administration for kids ages 2 to 17.

The spray vaccine is not new to the market—it was initially approved by the FDA in 2003, is available in healthcare settings (think: doctor’s offices and pharmacies), and is about as effective as the shot, per the CDC. What is new is that it no longer has to be administered by a medical provider, although you’ll still need a prescription.

“Today’s approval of the first influenza vaccine for self- or caregiver-administration provides a new option for receiving a safe and effective seasonal influenza vaccine potentially with greater convenience, flexibility and accessibility for individuals and families,” Peter Marks, MD, PhD, director of the FDA’s Center for Biologics Evaluation and Research, said in an announcement. “This approval adds another option for vaccination against influenza disease and demonstrates the FDA’s commitment to advancing public health.”

To take the at-home route, you’ll need to fill the prescription from your doctor through an online pharmacy, which will have you complete a screening to make sure you’re not at risk for any adverse reactions before shipping the spray to you. The spray comes with detailed instructions on how to administer it as well as info on proper storage and disposal.

Possible side effects of FluMist are similar to those that come with standard flu shots, including runny nose, congestion, and sore throat, as well as a low-grade fever in young children.

Most Medicaid, Medicare, and private insurance plans cover annual flu vaccines free of charge. This applies to FluMist administered in healthcare settings, but it is not immediately clear whether the at-home version will have the same coverage. The New York Times reports that the current out-of-pocket cost for a dose is between $35 and $45. The FDA has not yet provided a timeline on when the self-administered vaccine will be available, but the Times reports next fall as the tentative launch date.

For now, you’ll still need to visit your doctor’s office or local pharmacy to receive your flu shot or the FluMist spray. And if you haven’t gotten it already this year, now’s the perfect time (same goes for your annual COVID booster).